Differences in prevalence, intensity of infection and parasite-specific antibody levels do not predict different age-infection profiles: A study in two communities endemic for Schistosoma mansoni infections

APMIS

Volumn 110, Issue 7-8, 2002, Pages 535-544

  Abebe, F ^a   Gaarder, P I ^b   Petros, B ^c   Gundersen, S G ^a  

^a Institute of General Practice and Community Medicine   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

Antibody isotypes; Community; Ethiopia; Immunity; Peak shift; Schistosoma mansoni

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARASITE ANTIBODY; PARASITE ANTIGEN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; CHILD; CORRELATION FUNCTION; DIAGNOSTIC VALUE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHIOPIA; FEMALE; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; MALE; PREDICTION AND FORECASTING; PREVALENCE; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, HELMINTH; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ETHIOPIA; FECES; FEMALE; HUMANS; IMMUNOGLOBULIN ISOTYPES; INFANT; MALE; MIDDLE AGED; PARASITE EGG COUNT; PREVALENCE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS;

EID: 0036695890     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0463.2002.11007804.x     Document Type: Article

References (48)

1. Hagan P, Ndhlovu PD, Dunne DW. Schistosome immunology: more questions than answers. Parasitol Today 1998;14:407-12.
2. Dalton PR, Pole D. Water-contact patterns in relation to Schistosoma haematobium infection. Bull World Health Organ 1978;56:417-26.
3. Warren KS. Regulation of the prevalence and intensity of schistosomiasis in man: immunity or ecology. J Infect Dis 1973; 127: 595-609.
4. Mehdat A, Shehata M, Bucci K, et al. Increased interleukin-4 and interleukin-5 production in response to Schistosoma haematobium adult worm antigen correlates with lack of reinfection after treatment. J Infect Dis 1998;178:512-9.
5. Roberts M, Buttwerworth AE, Kimani G, et al. Immunity after treatment of schistosomiasis: association between cellular responses and resistance to reinfection. Infect Immun 1993;61:4984-93.
6. Hagan P, Blumenthal UJ, Dunne DW, Simpson AJ, Wilkens HA. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:234-45.
7. Rihet P, Demeure CE, Bourgois A, Prata A, Dessein AJ. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991;11:2679-86.
8. Dunne DW, Butterworth AE, Fulford AJC, et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigen and resistance to reinfection. Eur J Immunol 1992;22:1483-94.
9. Demeure CE, Rihet P, Abel L, et al. Resistance to Schistosoma mansoni in humans: influence of the IgE/IgG4 balance and IgG2 in immunity to reinfection after chemotherapy. J Infect Dis 1993;168:1000-8.
10. Grogan JL, Kremsner PG, van Dan GJ, Deelder AM, Yazdanbakhsh M. Anti-schistosome IgG4 and IgE at two years after chemotherapy: infected versus uninfected individuals. J Infect Dis 1997;176:1344-50.
11. Woolhouse MEJ, Taylor P, Matanhire D, Chandiwana SK. Acquired immunity and epidemiology of Schistosoma haematobium. Nature 1991;351:757-9.
12. Woolhouse MEJ. A theoretical framework for the immunoepidemiology of helminth infection. Parasite Immunol 1992;14:463-578.
13. Woolhouse MEJ. Immunoepidemiology of human schistosomes: taking the theory into the field. Parasitol Today 1994;10:196-202.
14. Hagan P. Reinfection, exposure and immunity in human schistosomiasis. Parasitol Today 1992;8:12-6.
15. Fisher AC. A study of schistosomiasis in the Stanleyville district of Congo. Trans R Soc Trop Med Hyg 1934;28:277-306.
16. Anderson RM, May RM. Herd immunity to helminth infection and implications for parasite control. Nature 1985;315:493-6.
17. Crombie JA, Anderson RM. Population dynamics of Schistosoma mansoni in mice repeatedly exposed to infection. Nature 1985;315:491-3.
18. Fulford AJC, Butterworth AE, Sturrock RF, Ouma JH. On the use of age intensity data to detect immunity to parasite infections, with special reference to Schistosoma mansoni in Kenya. Parasitology 1992;105:219-27.
19. Mutapi F, Ndholovu PD, Hagan P, Woolhouse MEJ. A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection. Parasite Immunol 1997;19:255-63.
20. Birrie H, Abebe F, Gundersen SG, et al. Epidemiology of Schistosomiasis mansoni in three endemic communities in northeast Ethiopia: baseline characteristics before endod based intervention. Ethiop Med J 1998;36:101-11.
21. Lemma A. A preliminary report on the molluscicidal property of endod (Phytolacca doedecandra). Ethiop Med J 1965;24:187-90.
22. Birrie H, Tedla S, Kloos H, Eshete H. Distribution of schistosomiasis in Ethiopia. In: Schistosomiasis in Ethiopia. Birrie H, Tedla S, Jemaneh L, editors. Addis Ababa Printing Press, 1998:29-86.
23. Peters PA, El-Alamy M, Warren KS, Mahmoud AAF. Quick kato smear for field quantification of S. mansoni eggs. Am J Trop Med Hyg 1980;29:217-319.
24. Abebe F, Gaarder, PI, Petros B, Gundersen SG. Age and sex-related differences in antibody responses against Schistosoma mansoni egg antigen in a cohort of school children in Ethiopia. APMIS 2001;109:816-24.
25. Birrie H. Survey of Schistosomiasis mansoni in the Borkena river basin. Ethiop Med J 1986;24:159-67.
26. Abebe F, Birkeland KI, Petros B, Gaarder PI, Gundersen SG. The relationships between dehydroepiandrosterone sulphate (DHEAS), the intensity of Schistosoma mansoni infection and parasite-specific antibody responses: a cross-sectional study in residents of endemic communities in northeast Ethiopia (submitted).
27. Alexander J, Stimson WH. Sex hormones and the course of parasitic infection. Parasitol Today 1988;4:189-93.
28. de Mendoca RL, Escriva H, Bouton D, Laudet V, Pierce RJ. Hormones and nuclear receptors in schistosome development. Parasitol Today 2000;16:233-40.
29. Fulford AJ, Webster M, Ouma JH, Kimani G, Dunne DW. Puberty and age-related changes in susceptibility to schistosome infection. Parasitol Today 1998;14:23-6.
30. Nakazaw M, Fantappie MR, Freeman GL, Eloi-Santos JS, Olsen NJ, Kovacs WJ, Secor WE, Coley DJ. Schistosoma mansoni: susceptibility differences between male and female mice can be mediated by testosterone during early infection. Exp Parasitol 1997;85:233-40.
31. Morales-Montor, J, Mohamed F, Ghaleb AM, Baig S, Halla-Calleros C, Damain RT. In vitro effects of hypothalamic-pituitary-adrenal axis (HPA) hormones on Schistosoma mansoni. J Parasitol 2001;87:1132-9.
32. Remoue F, Mani JC, Pugniere M, Schacht AM, Capron A, Riveau G. Functional specific binding of testosterone to Schistosoma haematobium 28-kilodalton glutathione S-transferase. Infect Immun 2002;70:601-5.
33. Capron A. Schistosomiasis: forty years of war on the worm. Parasitol Today 1998;14:379-84.
34. van Dam GJ, Stelma FF, Gryseels B, et al. Antibody response patterns against Schistosoma mansoni in a recently exposed community in Senegal. J Infect Dis 1996;173:1232-41.
35. Naus CWA, Kimani G, Ouma JH, et al. Development of isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age. Infect Immun 1999;67:3444-51.
36. Capron M, Capron A. Immunoglobulin E and effector cells in schistosomiasis. Science 1994;264:1876-7.
37. Cutts L, Wilson RA. Elimination of a primary schistosome infection from rats coincides with elevated IgE titres and mast cell degranulation. Parasite Immunol 1997;19:91-102.
38. Hagan P. IgE and protective immunity to helminth infections. Parasite Immunol 1993;15:1-4.
39. Pritchard DI. Immunity to helminths: is too much IgE parasite - rather than host-protective? Parasite Immunol 1993;15:5-9.
40. Fulford AJC, Kariuki HC, Langley JG, et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992;22:1483-94.
41. Webster M, Correa-Olveira R, Gazinelli G, et al. Factors affecting high and low human IgE responses to schistosome worm antigens in an area of Brazil endemic for Schistosoma mansoni and hookworm. Am J Trop Med Hyg 1997;57:487-94.
42. Nyindo M, Kariuki TM, Mola PW, et al. Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons. Infect Immun 1999;67:636-42.
43. Gryseels B. Human resistance to Schistosoma infections: age or experience? Parasitol Today 1994;10:380-4.
44. Kongs A, Marks G, Verle P, Van der Stuyft P. The unreliability of the Kato-Katz technique limits its usefulness for evaluating S. mansoni infections. Trop Med Int Hlth 2001;6:163-9.
45. Engels D, Sinzinkayo E, De Vlas SJ, Gryseels B. Intraspecimen fecal egg count variation in Schistosoma mansoni infection. Am J Trop Hyg 1997;57:571-7.
46. WHO. The control of schistosomiasis. Tech Rep Ser 1993;830.
47. Deelder AM, De Jonge N, Boerman OC, Fillie YE, Rotmans JP, Gerritse MJ, Schut DW. Sensitive determination of circulating anodic antigen in Schistosoma mansoni infected individuals by an enzyme-linked immunosorbent assay using monoclonal antibodies. Am J Trop Med Hyg 1989;40:268-72.
48. Ebrahim A. El-Morshedy H, Omer E, El Daly S, Barakat R. Evaluation of the Kato-Katz thick smear and the formol-ether sedimentation technique for quantitative diagnosis of Schistosoma mansoni. Am J Trop Med Hyg 1997;57:706-8.